About Genomica
Genomica is a company based in Madrid (Spain) founded in 1990 was acquired by Exelis in November 2001. Genomica operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and Agendia, among others.
- Headquarter Madrid, Spain
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Exelis
(Nov 22, 2001)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genomica
Detailed funding history for Genomica
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Genomica
Genomica has secured backing from 1 investor. Prominent investors backing the company include Exelis Inc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Integrated electronic warfare products are manufactured for aerospace applications.
|
Locked | Locked | Locked |
Investor details for Genomica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genomica
Investment portfolio details for Genomica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genomica
Detailed financials for Genomica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genomica Comparisons
Peer comparison for Genomica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genomica
Genomica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and Agendia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Genomic diagnostic products for cancer treatment are provided.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
Detailed competitors of Genomica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genomica
Complete news archive for Genomica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genomica
Genomica was founded in 1990.
Genomica is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
The company was founded in 1990 and is based in Madrid, Spain, operating within the biotechnology sector focused on molecular diagnostics. Products and services are offered, including the CLART microarray platform for multiplex target detection in single runs. Assays target various infectious diseases, with results processed through dedicated Clinical Array Reader software. Operations emphasize automated analysis for clinical applications.
Genomica's top competitors include Visby Medical, Inflammatix and MeMed.
Genomica has 1 investor. Key investors include Exelis Inc.